Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
van Harten, Peter N.
and
Tenback, Diederik E.
2011.
Pathophysiology, Pharmacology, and Biochemistry of Dyskinesia.
Vol. 98,
Issue. ,
p.
187.
Preda, Adrian
Bota, Robert
and
Harvey, Philip
2011.
Handbook of Schizophrenia Spectrum Disorders, Volume II.
p.
33.
Blanchet, Pierre J.
Normandeau, Louise
and
Rompré, Pierre H.
2012.
Comparing three screening tools for drug-induced parkinsonism in patients with advanced schizophrenia: A pilot study.
Schizophrenia Research,
Vol. 137,
Issue. 1-3,
p.
230.
Gourzis, Philippos
Skokou, Maria
Soubasi, Evanthia
Katrivanou, Aggeliki
and
Polychronopoulos, Panagiotis
2015.
Treatment of Tardive Dystonia Induced by Antipsychotics, Old and New.
Clinical Neuropharmacology,
Vol. 38,
Issue. 4,
p.
121.
Lockwood, Jonathan Tomas
and
Remington, Gary
2015.
Emerging drugs for antipsychotic-induced tardive dyskinesia: investigational drugs in Phase II and Phase III clinical trials.
Expert Opinion on Emerging Drugs,
Vol. 20,
Issue. 3,
p.
407.
Hauser, Robert A.
Factor, Stewart A.
Marder, Stephen R.
Knesevich, Mary Ann
Ramirez, Paul M.
Jimenez, Roland
Burke, Joshua
Liang, Grace S.
and
O’Brien, Christopher F.
2017.
KINECT 3: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Valbenazine for Tardive Dyskinesia.
American Journal of Psychiatry,
Vol. 174,
Issue. 5,
p.
476.
Maier, Franziska
and
Prigatano, George P
2017.
Impaired Self-Awareness of Motor Disturbances in Parkinson's Disease.
Archives of Clinical Neuropsychology,
Vol. 32,
Issue. 7,
p.
802.
Strassnig, Martin
Rosenfeld, Amie
and
Harvey, Philip D.
2018.
Tardive dyskinesia: motor system impairments, cognition and everyday functioning.
CNS Spectrums,
Vol. 23,
Issue. 6,
p.
370.
Niemann, Nicki
and
Jankovic, Joseph
2018.
Treatment of Tardive Dyskinesia: A General Overview with Focus on the Vesicular Monoamine Transporter 2 Inhibitors.
Drugs,
Vol. 78,
Issue. 5,
p.
525.
Balint, Bettina
Killaspy, Helen
Marston, Louise
Barnes, Thomas
Latorre, Anna
Joyce, Eileen
Clarke, Caroline S.
De Micco, Rosa
Edwards, Mark J.
Erro, Roberto
Foltynie, Thomas
Hunter, Rachael M.
Nolan, Fiona
Schrag, Anette
Freemantle, Nick
Foreshaw, Yvonne
Green, Nicholas
Bhatia, Kailash P.
and
Martino, Davide
2018.
Development and clinimetric assessment of a nurse-administered screening tool for movement disorders in psychosis.
BJPsych Open,
Vol. 4,
Issue. 5,
p.
404.
Gaebel, Wolfgang
Hasan, Alkomiet
and
Falkai, Peter
2019.
S3-Leitlinie Schizophrenie.
p.
51.
Marder, Stephen R.
Singer, Carlos
Lindenmayer, Jean-Pierre
Tanner, Caroline M.
Comella, Cynthia L.
Verghese, Cherian
Jimenez, Roland
Liang, Grace S.
Burke, Joshua
and
O'Brien, Christopher F.
2019.
A Phase 3, 1-Year, Open-Label Trial of Valbenazine in Adults With Tardive Dyskinesia.
Journal of Clinical Psychopharmacology,
Vol. 39,
Issue. 6,
p.
620.
Stacy, Mark
Sajatovic, Martha
Kane, John M.
Cutler, Andrew J.
Liang, Grace S.
O'Brien, Christopher F.
and
Correll, Christoph U.
2019.
Abnormal involuntary movement scale in tardive dyskinesia: Minimal clinically important difference.
Movement Disorders,
Vol. 34,
Issue. 8,
p.
1203.
Buchwitz, Timo Marcel
Maier, Franziska
Greuel, Andrea
and
Eggers, Carsten
2020.
Improving Self-Awareness of Motor Symptoms in Patients With Parkinson’s Disease by Using Mindfulness – A Study Protocol for a Randomized Controlled Trial.
Frontiers in Psychology,
Vol. 11,
Issue. ,
Freudenreich, Oliver
2020.
Psychotic Disorders.
p.
411.
Caroff, Stanley N.
Leong, Shirley H.
Roberts, Christopher
Berkowitz, Rosalind M.
and
Campbell, E. Cabrina
2020.
Cumulative Burden of Illness in Veterans With Tardive Dyskinesia and Serious Mental Disorders.
Journal of Clinical Psychopharmacology,
Vol. 40,
Issue. 1,
p.
38.
Blanchet, Pierre J.
2020.
A Focused Update on Tardive Dyskinesia.
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques,
Vol. 47,
Issue. 6,
p.
747.
Little, John D.
2021.
In schizophrenia, are lack of capacity and lack of insight more usefully understood as anosognosia?.
Australasian Psychiatry,
Vol. 29,
Issue. 3,
p.
346.
Rekhi, Gurpreet
Tay, Jenny
and
Lee, Jimmy
2022.
Impact of drug-induced Parkinsonism and tardive dyskinesia on health-related quality of life in schizophrenia.
Journal of Psychopharmacology,
Vol. 36,
Issue. 2,
p.
183.
Foucher, Jack René
de Billy, Clément
Schorr, Benoit
Vercueil, Laurent
Obrecht, Alexandre
Mainberger, Olivier
Clauss, Julie M.E.
Weibel, Sébastien
Elowe, Julien
Bregeon, Efflam
Doligez, Nelly
Dormegny-Jeanjean, Ludovic C.
and
Berna, Fabrice
2022.
Les parakinésies. Phénoménologie des mouvements anormaux intrinsèques aux psychoses endogènes.
Annales Médico-psychologiques, revue psychiatrique,
Vol. 180,
Issue. 6,
p.
588.
Comments
No Comments have been published for this article.